Chen, H. H. et al. Therapeutic effects of Honokiol on motor impairment in Hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARγ regulation. Biomed. Pharmacother. 108, 254–262.
Inhibition of levodopa metabolism to dopamine by honokiol short-chain fatty acid derivatives may enhance therapeutic efficacy in Parkinson’s disease
